2022 annual financial data
Cadrenal Therapeutics 2022 Operating margin
Cadrenal Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -2,701,630 USD and net income was -6,714,329 USD.
Operating cash flow was -1,204,770 USD.
Get free Cadrenal Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -2,701,630 USD
- Net income
- -6,714,329 USD
- Operating cash flow
- -1,204,770 USD